Short‐Chain Fatty Acid–Dependent Neuroimmune Regulation in Autism Spectrum Disorder Pathogenesis
European Journal of Neuroscience · 2026-07 · 64 (2)
DOI: 10.1111/ejn.70637 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 18.07.2026. Verfasst von Arpan Dhungel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmaceutical Science, Assam down town University, Guwahati, Assam, India. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Autism Spectrum Disorder, Neuroimmunomodulation, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Autism spectrum disorder manifests through dysbiosis across the microbiota–gut–brain–immune axis, characterized by depletion of short‐chain fatty acid (SCFA)–producing taxa like Bifidobacterium , Faecalibacterium , and Roseburia , along with an increase in endotoxin‐producing taxa like Desulfovibrio and Bacteroides . SCFA emerge as one of the regulators of neuroimmune homeostasis by governing microglial maturation through GPR43/GPR109A‐dependent histone deacetylase inhibition, modulating astrocytic tryptophan‐aryl hydrocarbon receptor signaling, and preserving tight junction integrity at blood–brain and blood–CSF barriers. SCFA insufficiency constitutes the upstream metabolic defect linking gut dysbiosis to ASD neuropathology, such as impaired microglial priming and brain‐resident CD4+ T cell differentiation, reactive astrocytosis with kynurenine neurotoxicity superseding protective signaling, barrier breakdown enabling LPS‐driven TLR4–NF‐κB neuroinflammation, and excitatory/inhibitory imbalance from reduced glutamate decarboxylase and astrocyte glutamate dysregulation. This review advances an integrative SCFA‐centric framework repositioning ASD as metabolite‐dependent neuroimmune dysregulation during brain development. Preclinical and early clinical data demonstrate that SCFA restoration through prebiotic fiber/resistant starch, probiotics, or direct SCFA supplementation normalizes gastrointestinal symptoms, behavioral deficits, microglial morphology, and neurotransmitter ratios. This guides mechanistically targeted microbiota interventions with fecal/plasma SCFA profiling as stratification biomarkers, establishing precision therapeutic regimens for ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmaceutical Science, Assam down town University, Guwahati, Assam, India.
ORCID-Profile: Arpan Dhungel, Rinchi Bora
Zitieren
APA
Dhungel, A., & Bora, R. (2026). Short‐Chain Fatty Acid–Dependent Neuroimmune Regulation in Autism Spectrum Disorder Pathogenesis. European Journal of Neuroscience, 64(2). https://doi.org/10.1111/ejn.70637
Vancouver
Dhungel A, Bora R. Short‐Chain Fatty Acid–Dependent Neuroimmune Regulation in Autism Spectrum Disorder Pathogenesis. European Journal of Neuroscience. 2026;64(2). doi:10.1111/ejn.70637
BibTeX
@article{Dhungel2026,
author = {Dhungel, Arpan and Bora, Rinchi},
title = {Short‐Chain Fatty Acid–Dependent Neuroimmune Regulation in Autism Spectrum Disorder Pathogenesis},
journal = {European Journal of Neuroscience},
year = {2026},
volume = {64},
number = {2},
doi = {10.1111/ejn.70637}
}
EUVIMED